FGF5 and FGFR3

  • Number of citations of the paper that reports this interaction (PMID 8663044)
  • 243
  • Data Source:
  • HPRD (in vitro)

FGF5

FGFR3

Gene Name fibroblast growth factor 5 fibroblast growth factor receptor 3
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 4 interactors: FGFR1 FGFR2 FGFR3 FGFR4 38 interactors: ARAP1 ATF3 BORA C6orf47 CCDC17 CHGB CTSK EPHA4 FGF1 FGF17 FGF18 FGF2 FGF23 FGF3 FGF4 FGF5 FGF6 FGF7 FGF8 FGF9 GPSM3 GRB2 GTF3C1 HBZ HNRNPL KIAA1377 KRT8 NDUFS6 POLA2 PTK2B RADIL RNF130 RPL8 SH2B1 SLC25A6 SMG7 STAT1 STAT3
Entrez ID 2250 2261
HPRD ID 01307 00624
Ensembl ID ENSG00000138675 ENSG00000068078
Uniprot IDs P12034 Q6A549 Q8NBG6 Q8NF90 P22607 Q0IJ44
PDB IDs 1RY7 4K33
Enriched GO Terms of Interacting Partners?
Tagcloud ?
3p  accordingly  bodies  brachyury  cbx4  cbx7  chemicals  ectodermal  embryoid  endodermal  foxa2  ideal  markers  meanwhile  mebs  mesodermal  nanog  nestin  oct4  pcg  perfluorooctane  pfos  pluripotency  polycomb  poses  sma  sox17  sox2  sulfonate 
accrue  alterations  amplified  approved  braf  carry  cdkn2a  copy  cscc  csccs  cutaneous  deleted  drivers  fda  genomic  genomically  guide  inferior  metastasize  metastatic  neck  notch1  oncogenic  pik3ca  recurrently  rtk  sccs  squamous  varying 
Tagcloud (Difference) ?
3p  accordingly  bodies  brachyury  cbx4  cbx7  chemicals  ectodermal  embryoid  endodermal  foxa2  ideal  markers  meanwhile  mebs  mesodermal  nanog  nestin  oct4  pcg  perfluorooctane  pfos  pluripotency  polycomb  poses  sma  sox17  sox2  sulfonate 
accrue  alterations  amplified  approved  braf  carry  cdkn2a  copy  cscc  csccs  cutaneous  deleted  drivers  fda  genomic  genomically  guide  inferior  metastasize  metastatic  neck  notch1  oncogenic  pik3ca  recurrently  rtk  sccs  squamous  varying 
Tagcloud (Intersection) ?